Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kieran Adam

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Bio-Protocol|August 18, 2022
Immunohistochemistry of Immune Cells and Cells Bound to <i>in vivo</i> Administered Antibodies in Liver, Lung, Pancreas, and Colon of B6/lpr MiceKieran Adam, Adam Mor
Data in Brief|June 11, 2021
Data on the identification of VRK2 as a mediator of PD-1 functionMichael Peled, Kieran Adam, Adam Mor
Immunology Letters|March 20, 2021
VRK2 inhibition synergizes with PD-1 blockade to improve T cell responsesMichael Peled, Anna S Tocheva, Kieran Adam, et al.
Plos One|February 11, 2021
A novel mouse model for checkpoint inhibitor-induced adverse eventsKieran Adam, Alina Iuga, Anna S Tocheva, et al.
Iscience|September 15, 2021
PD-1-stimulated T cell subsets are transcriptionally and functionally distinctShalom Lerrer, Anna S Tocheva, Shoiab Bukhari, et al.
Communications Biology|June 4, 2021
Transmembrane adaptor protein PAG is a mediator of PD-1 inhibitory signaling in human T cellsMarianne Strazza, Inbar Azoulay-Alfaguter, Michael Peled, et al.
Trends in Cancer|November 27, 2024
Advances in LAG3 cancer immunotherapeuticsKieran Adam, Samuel C Butler, Creg J Workman, et al.
Molecular Therapy. Methods & Clinical Development|November 24, 2022
Neutralization of the adaptor protein PAG by monoclonal antibody limits murine tumor growthMarianne Strazza, Emily K Moore, Kieran Adam, et al.
Inflammation|February 24, 2021
SHP2 Targets ITK Downstream of PD-1 to Inhibit T Cell FunctionMarianne Strazza, Kieran Adam, Shalom Lerrer, et al.
Plos One|June 15, 2019
SLAMF6 clustering is required to augment T cell activationMatthew A Dragovich, Kieran Adam, Marianne Strazza, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Bio-Protocol|August 18, 2022
Immunohistochemistry of Immune Cells and Cells Bound to <i>in vivo</i> Administered Antibodies in Liver, Lung, Pancreas, and Colon of B6/lpr MiceKieran Adam, Adam Mor
Data in Brief|June 11, 2021
Data on the identification of VRK2 as a mediator of PD-1 functionMichael Peled, Kieran Adam, Adam Mor
Immunology Letters|March 20, 2021
VRK2 inhibition synergizes with PD-1 blockade to improve T cell responsesMichael Peled, Anna S Tocheva, Kieran Adam, et al.
Plos One|February 11, 2021
A novel mouse model for checkpoint inhibitor-induced adverse eventsKieran Adam, Alina Iuga, Anna S Tocheva, et al.
Iscience|September 15, 2021
PD-1-stimulated T cell subsets are transcriptionally and functionally distinctShalom Lerrer, Anna S Tocheva, Shoiab Bukhari, et al.
Communications Biology|June 4, 2021
Transmembrane adaptor protein PAG is a mediator of PD-1 inhibitory signaling in human T cellsMarianne Strazza, Inbar Azoulay-Alfaguter, Michael Peled, et al.
Trends in Cancer|November 27, 2024
Advances in LAG3 cancer immunotherapeuticsKieran Adam, Samuel C Butler, Creg J Workman, et al.
Molecular Therapy. Methods & Clinical Development|November 24, 2022
Neutralization of the adaptor protein PAG by monoclonal antibody limits murine tumor growthMarianne Strazza, Emily K Moore, Kieran Adam, et al.
Inflammation|February 24, 2021
SHP2 Targets ITK Downstream of PD-1 to Inhibit T Cell FunctionMarianne Strazza, Kieran Adam, Shalom Lerrer, et al.
Plos One|June 15, 2019
SLAMF6 clustering is required to augment T cell activationMatthew A Dragovich, Kieran Adam, Marianne Strazza, et al.
Pageof 2